Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06782945 · ClinicalTrials.gov registry record
Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms
A clinical trial of Moderate Gastrointestinal Discomfort, sponsored by Biohm Technologies.
- Active
- Registry status
- 141
- Enrollment target
- 1
- Study location
NCT06782945 is a study of Moderate Gastrointestinal Discomfort that is active but no longer recruiting, run by Biohm Technologies. The registered enrollment target is 141 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06782945, a study of Moderate Gastrointestinal Discomfort, is active but no longer recruiting, sponsored by Biohm Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The rationale for this study is to observe the effect of two different doses of a consumer-grade probiotic product called FX Probiotic Blend on digestive symptoms in individuals with moderate gastrointestinal discomfort. Additionally, the study aims to observe the effects of the probiotic product on anxiety and quality of life, as well as effects on gut microbiota via activities and technologies that can successfully and effectively be completed and utilized in a home setting. Because this product is currently available in the overt the counter (OTC) market across the United States, a consumer-driven, decentralized observational clinical research study is therefore well-suited for examining the effects of this probiotic product in this population.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT BIOHM FX Probiotic Blend
Study Locations (1)
California
- People Science, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2024-07-24 |
| Est. Completion | 2025-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06782945
The ClinicalTrials.gov registry entry for NCT06782945 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biohm Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Moderate Gastrointestinal Discomfort appearing as the primary indexed condition, and to 1 intervention - of which BIOHM FX Probiotic Blend is the first listed.
NCT06782945 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06782945 about?
NCT06782945 is a clinical study titled "Investigating the Effectiveness of 2 Different Doses of BIOHM FX Probiotic Blend in Improving Digestive Symptoms". The rationale for this study is to observe the effect of two different doses of a consumer-grade probiotic product called FX Probiotic Blend on digestive symptoms in individuals with moderate gastrointestinal discomfort. Additionally, the study aims to observe the effects of the probiotic product on...
What is the current status of trial NCT06782945?
This trial is currently active not recruiting. The enrollment target is 141 participants. The study started on 2024-07-24. Estimated completion is 2025-03-04.
What conditions does trial NCT06782945 study?
This clinical trial studies the following conditions: Moderate Gastrointestinal Discomfort.
What interventions are being tested in trial NCT06782945?
The interventions under investigation include: BIOHM FX Probiotic Blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06782945?
This trial is sponsored by Biohm Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06782945 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.